title: Phase II study of combination vincristine, epirubicin and cyclophosphamide in advanced breast cancer in Chinese patients.
authors.forename: W
authors.initials: W
authors.lastname: Shiu
authors.forename: M
authors.initials: M
authors.lastname: Tao
authors.forename: T
authors.initials: T
authors.lastname: Leung
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002681:China; D003520:Cyclophosphamide / Q000008:administration & dosage; D004341:Drug Evaluation; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D014750:Vincristine; D003520:Cyclophosphamide